Fertility is far more than timing and chance—it is a reflection of your body’s overall health, cellular function, hormone balance, and toxic burden. That is why, so often, reproductive health challenges stem from underlying physiological imbalances that conventional fertility treatments fail to address. Unfortunately, these rudimentary causes go undetected, even by trained fertility specialists.
Our advanced fertility optimization program takes a comprehensive, root-cause approach to reproductive health—for both men and women. Rather than simply rushing toward assisted reproductive technologies, we focus on restoring your body’s natural fertility by addressing things like hormone dysregulation, cellular dysfunction, toxin accumulation, and chronic inflammation, all of which can interfere with conception and healthy pregnancy.
Beyond Conventional Fertility Treatment
Most fertility clinics focus on achieving pregnancy as quickly as possible, through medications, ovulation induction, intrauterine insemination, and in vitro fertilization. While these interventions have their place, and can be very effective, they often overlook the fundamental question: Why is the body not conceiving naturally?
Our approach is fundamentally different. We work to make your body healthy enough to conceive and carry a baby naturally by removing the obstacles that prevent reproductive function. This means addressing heavy metal toxicity, endocrine-disrupting chemicals, nutritional deficiencies, hormone imbalances, and inflammatory conditions that damage eggs and sperm while disrupting the delicate hormonal orchestration required for conception.
Many of our patients conceive naturally after addressing underlying issues that were never identified during conventional fertility workups. More importantly, the result is not just pregnancy, but healthier pregnancies and the potential for improved long-term health for both parents and children.
Fertility Therapies
At The Longevity Centers, we offer four main approaches to optimize fertility.
PRP Therapy for Ovaries
Platelet-rich plasma (PRP) therapy for ovaries represents a groundbreaking regenerative approach to female fertility challenges, particularly for women experiencing diminished ovarian reserve, poor egg quality, or premature ovarian aging. This innovative therapy uses your own platelet-rich plasma—concentrated from a simple blood draw—to rejuvenate ovarian tissue and improve egg quality at the cellular level.1
Our PRP therapy procedure involves extracting a small amount of your blood, concentrating the platelets through centrifugation, and injecting the platelet-rich plasma directly into the ovaries under ultrasound guidance. The therapy is performed as an outpatient procedure with minimal discomfort and no downtime.
The science behind ovarian PRP therapy is compelling. Platelets contain powerful growth factors that stimulate tissue regeneration, enhance blood flow, and activate dormant follicles. When these concentrated growth factors are delivered directly to the ovaries, they can restore cellular function, improve the ovarian microenvironment, and support the development of healthier eggs.2
This therapy is particularly valuable for women who have been told their egg quality is poor, those with elevated FSH levels indicating diminished ovarian reserve, women experiencing early menopause, or anyone seeking to optimize egg quality before attempting conception. Unlike conventional fertility drugs that simply push the ovaries harder, PRP therapy actually improves the underlying health and regenerative capacity of ovarian tissue.
Potential benefits of PRP therapy for ovaries:
- Improved ovarian function and enhanced egg quality
- Support of natural hormone production, including estrogen and progesterone
- Reversal of premature ovarian aging and extension of the reproductive window
- Non-invasive regenerative approach with minimal side effects
- Improved response to fertility treatments
- Addressing root causes rather than simply masking symptoms
Many women notice improvements in menstrual regularity, hormone levels, and overall reproductive health within weeks after PRP therapy. While not every woman will achieve pregnancy through this therapy alone, it significantly improves the underlying conditions necessary for natural conception and healthy pregnancy.
VSELs Therapy for Fertility
VSELs therapy for fertility represents the frontier of regenerative reproductive medicine. This advanced therapy uses “very small embryonic-like stem cells,” which are found in your own blood, to regenerate ovarian and testicular tissue, restore reproductive function, and support natural fertility in both men and women.3
The therapy involves harvesting VSELs from your blood, then delivering them with precision directly to the ovaries or testes using advanced Song laser-guided technology. This ensures accurate placement and optimal therapeutic effect. Once delivered, the stem cells begin the regeneration process—potentially reversing reproductive aging and restoring natural fertility.
What makes VSELs therapy particularly revolutionary is its ability to potentially regenerate reproductive tissue that conventional medicine considers permanently damaged or aged. These rare stem cells have the remarkable capacity to differentiate into various cell types, including those needed for ovarian follicle development and sperm production.
Potential benefits of VSELs therapy for fertility include:
- Regenerating ovarian tissue in women and testicular tissue in men
- Supporting natural fertility restoration through actual tissue regeneration
- Using your own stem cells for maximum safety and compatibility
- Precision delivery using advanced Song laser-guided precision delivery, ensuring optimal results
- Help for patients who have exhausted other fertility options
- Addressing age-related reproductive decline at the cellular level
VSELs therapy is particularly promising for women with premature ovarian insufficiency, diminished ovarian reserve, or poor ovarian response to conventional fertility treatments. For men, it offers hope for conditions where sperm production is significantly impaired.
While VSELs therapy for fertility is still considered cutting-edge, early results have been remarkable. Women who were told they had no viable eggs have achieved pregnancy. Men with severely compromised sperm production have seen improvements. For these reasons, this therapy represents genuine hope for couples facing the most challenging fertility obstacles.
Why Choose LCOA
What Sets Longevity Centers of America Apart?
- Personalized protocols tailored to your unique health goals
- Physician-led team with advanced training in functional and longevity medicine
- In-depth testing and root-cause diagnostics
- Concierge-level care and long-term support
- Proven therapies backed by science
- A calm, comfortable, and discreet environment
Enclomiphene Therapy
Male factor infertility contributes to approximately half of all infertility challenges,4 yet men’s reproductive health is often overlooked in fertility treatment. Enclomiphene therapy offers a powerful natural approach to boosting testosterone levels, improving sperm production, and enhancing male fertility, all while maintaining the body’s natural hormone production pathways.
Unlike testosterone replacement therapy, which shuts down natural testosterone and sperm production, enclomiphene works by blocking estrogen receptors in the brain and pituitary gland. This triggers increased production of hormones that are responsible for stimulating sperm production in the testes.5
Exogenous testosterone suppresses sperm production and can render men temporarily infertile. Enclomiphene therapy, by contrast, increases both testosterone and sperm production simultaneously, making it ideal for men who want to optimize hormonal health while maintaining or improving fertility.
Potential enclomiphene therapy benefits for male fertility include:
- Natural increase of testosterone, without suppressing sperm production
- Improved sperm count
- Maintenance of natural hormone production pathways
- Safe alternative to testosterone replacement for men seeking fertility
- Improved energy, libido, and overall vitality
- Reversal of the negative effects of previous testosterone use on fertility
Enclomiphene therapy is particularly valuable for men with low testosterone coupled with fertility concerns, those who have experienced fertility decline while on testosterone replacement, or men with low sperm count without identified causes.
The therapy is oral, convenient, and generally well-tolerated with minimal side effects. Most men notice improvements in energy, mood, and sexual function within weeks, while sperm parameters typically improve over two to three months—the time required for new sperm to mature. Regular monitoring ensures optimal dosing and confirms improvements in both hormone levels and semen analysis parameters.
Comprehensive Fertility Program
Our comprehensive fertility program goes far beyond basic fertility testing to identify and address many of the factors that might be interfering with your ability to conceive or achieve a healthy pregnancy. This program represents our most thorough approach to fertility support, examining the complex web of hormones, toxins, nutrients, inflammation, and cellular function that determines reproductive health.
Our program includes hormone testing for both men and women, and ultrasound imaging for women. While these tests provide a useful starting point, they do not necessarily identify all potential factors that could be impacting fertility. That is why we also look at heavy metal accumulation, mold toxicity, endocrine-disrupting chemicals, mitochondrial dysfunction, autoimmune inflammation, and micronutrient deficiencies, all of which frequently fly below the radar in conventional fertility clinics. We assess heavy metal burden through urine testing, evaluate hormone levels throughout the menstrual cycle for women, check for nutrient deficiencies that can affect egg quality and sperm count, measure inflammatory markers, and evaluate thyroid function.
Comprehensive fertility program components:
- Complete health assessment for both partners, identifying all fertility factors
- Toxin screening and personalized detoxification protocols to remove reproductive poisons
- Hormone optimization for both partners using bioidentical hormones when needed
- Nutritional repletion, addressing micronutrient deficiencies critical for fertility
- Inflammatory condition therapy, including autoimmune issues affecting reproduction
- Cellular health optimization supporting egg quality and sperm quality at the mitochondrial level
- Lifestyle and stress management guidance recognizing psychological factors in fertility
Your personalized plan might include maternal detoxification using EBOOSTTM ozone IV therapy to remove accumulated toxins before conception, chelation therapy to eliminate heavy metals that damage gametes, hormone replacement therapy for women to optimize the menstrual cycle and support implantation, enclomiphene for men to boost natural testosterone and sperm production, or anti-inflammatory protocols.
The comprehensive fertility program is ideal for couples who have struggled with unexplained infertility, those who have experienced recurrent pregnancy loss, individuals who have failed IVF cycles, or anyone who wants to optimize their health before attempting conception. By addressing root causes—rather than simply bypassing them with assisted reproductive technology—we can help create the physiological foundation for natural, healthy conception and pregnancy.
References
- Jacques Pretorius, Mohammed Habash, and Bishoy Ghobrial, “Current Status and Advancements in Platelet-Rich Plasma Therapy,” Cureus, October 2023, https://pmc.ncbi.nlm.nih.gov/articles/PMC10652151/.
- Po-Han Chen, Xiaoyan Chen, and Xiaolin He, “Platelet-derived growth factors and their receptors: structural and functional perspectives,” Biochimica et Biophysica Acta, October 2014, https://pmc.ncbi.nlm.nih.gov/articles/PMC3612563/.
- Mariusz Z. Ratajczak, Janina Ratajczak, and Magda Kucia, “Very Small Embryonic-Like Stem Cells (VSELs) – an update and future directions,” Circulation Research, January 2019, https://pmc.ncbi.nlm.nih.gov/articles/PMC6461217/.
- Stephen W. Leslie, Taylor L. Soon-Sutton, and Moien A.B. Khan, “Male Infertility,” National Center for Biotechnology Information, National Library of Medicine, February 2024, https://www.ncbi.nlm.nih.gov/books/NBK562258/.
- Ronald Wiehle, Glenn R. Cunningham, Nelly Pitteloud, et al., “Testosterone restoration using enclomiphene citrate in men with secondary hypogonadism: a pharmacodynamic and pharmacokinetic study,” BJU International, https://pmc.ncbi.nlm.nih.gov/articles/PMC4155868/.